BACKGROUND: Intestinal alkaline phosphatase (IAP) as a tissue-specific isozyme of alkaline phosphatases is predominantly produced by enterocytes in the proximal small intestine. In recent years, an increasing number of pathologies have been identified to be associated with an IAP deficiency, making it very worthwhile to review the various roles, biological functions, and potential therapeutic aspects of IAP. SUMMARY: IAP primarily originates and acts in the intestinal tract but affects other organs through specific biological axes related to its fundamental roles such as promoting gut barrier function, dephosphorylation/detoxification of lipopolysaccharides (LPS), and regulation of gut microbiota. KEY MESSAGES: Numerous studies reporting on the different roles and the potential therapeutic value of IAP across species have been published during the last decade. While IAP deficiency is linked to varying degrees of physiological dysfunctions across multiple organ systems, the supplementation of IAP has been proven to be beneficial in several translational and clinical studies. The increasing evidence of the salutary functions of IAP underlines the significance of the naturally occurring brush border enzyme.
BACKGROUND: Intestinal alkaline phosphatase (IAP) as a tissue-specific isozyme of alkaline phosphatases is predominantly produced by enterocytes in the proximal small intestine. In recent years, an increasing number of pathologies have been identified to be associated with an IAP deficiency, making it very worthwhile to review the various roles, biological functions, and potential therapeutic aspects of IAP. SUMMARY: IAP primarily originates and acts in the intestinal tract but affects other organs through specific biological axes related to its fundamental roles such as promoting gut barrier function, dephosphorylation/detoxification of lipopolysaccharides (LPS), and regulation of gut microbiota. KEY MESSAGES: Numerous studies reporting on the different roles and the potential therapeutic value of IAP across species have been published during the last decade. While IAP deficiency is linked to varying degrees of physiological dysfunctions across multiple organ systems, the supplementation of IAP has been proven to be beneficial in several translational and clinical studies. The increasing evidence of the salutary functions of IAP underlines the significance of the naturally occurring brush border enzyme.
Authors: K P Economopoulos; N L Ward; C D Phillips; A Teshager; P Patel; M M Mohamed; S Hakimian; S B Cox; R Ahmed; O Moaven; K Kaliannan; S N Alam; J F Haller; A M Goldstein; A K Bhan; M S Malo; R A Hodin Journal: Diabetes Obes Metab Date: 2016-03-22 Impact factor: 6.577
Authors: P Martínez-Moya; M Ortega-González; R González; A Anzola; B Ocón; C Hernández-Chirlaque; R López-Posadas; M D Suárez; A Zarzuelo; O Martínez-Augustin; F Sánchez de Medina Journal: Pharmacol Res Date: 2012-05-05 Impact factor: 7.658
Authors: Suzanne Kats; Ruud Brands; Mohamed A Soliman Hamad; Willem Seinen; Volkher Scharnhorst; Raymond W Wulkan; Jacques P Schönberger; Wim van Oeveren Journal: Int J Artif Organs Date: 2012-02 Impact factor: 1.595
Authors: Esther Peters; Tom Schirris; Alexander H van Asbeck; Jelle Gerretsen; Jennifer Eymael; Angel Ashikov; Merel J W Adjobo-Hermans; Frans Russel; Peter Pickkers; Rosalinde Masereeuw Journal: Eur J Pharmacol Date: 2016-12-22 Impact factor: 4.432
Authors: Milan Lukas; Pavel Drastich; Michal Konecny; Paolo Gionchetti; Ondrej Urban; Franco Cantoni; Martin Bortlik; Dana Duricova; Michael Bulitta Journal: Inflamm Bowel Dis Date: 2010-07 Impact factor: 5.325
Authors: Esther Peters; Jasper Stevens; Jacques Arend; Zheng Guan; Willem Raaben; Peter Laverman; Andrea van Elsas; Rosalinde Masereeuw; Peter Pickkers Journal: Int J Pharm Date: 2015-09-07 Impact factor: 5.875